Transmembrane and immunoglobulin domain-containing 2 (TMIGD2) serves as the receptor for HHLA2, and the level of this protein is limited in normal tissues but high in many malignant carcinomas (97, 98). This evidence concerns the gene TMIGD2 and carcinoma.